O'Day Bonnie, Kieffer Tessa, Forrestal Sarah, Esposito Dominick
Mathematica Policy Research, 1100 First Street NE, Suite 1200, Washington, DC 20002, USA.
J Comp Eff Res. 2014 Nov;3(6):591-600. doi: 10.2217/cer.14.56.
This article describes American Reinvestment and Recovery Act comparative effectiveness research data infrastructure (DI) investments and identifies facilitators and barriers to implementation.
MATERIALS & METHODS: We reviewed original project proposals, conducted an investigator survey and interviewed project officers and principal investigators.
DI projects assembled or enhanced existing clinical datasets, established linkages between public and private data sources and built infrastructure. Facilitators included building on existing relationships across organizations and making collection as seamless as possible for clinicians.
To sustain DI, investigators should reduce the burden of comparative effectiveness research data collection on practices, adequately address data privacy and security issues, resolve or lessen the impact of data-linking issues and build research capacity for other investigators and clinicians.
本文描述了《美国再投资与复苏法案》比较效果研究数据基础设施(DI)投资情况,并确定了实施过程中的促进因素和障碍。
我们审查了原始项目提案,开展了一项调查员调查,并对项目官员和主要研究者进行了访谈。
DI项目整合或强化了现有的临床数据集,建立了公共和私人数据源之间的联系,并构建了基础设施。促进因素包括基于各组织间现有的关系,以及尽可能为临床医生简化数据收集流程。
为维持DI,研究者应减轻比较效果研究数据收集对医疗机构的负担,充分解决数据隐私和安全问题,解决或减轻数据链接问题的影响,并为其他研究者和临床医生培养研究能力。